Analystreport

Oyster Point Pharma (NASDAQ: OYST) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating.

Oyster Point Pharma, Inc. - common stock  (OYST) 
Last oyster point pharma, inc. - common stock earnings: 2/27 04:01 pm Check Earnings Report